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Summary 
Although interlenkin 1 (IL-1) receptor signaling events in T helper lymphocytes are incompletely 
characterized, events assodated with translocation of the transcription factor NF-KB are receptor- 
proximal assays of ligand-initiated responses. In this report we demonstrate that the transient 
nature of IL-l-induced NF-JcB nuclear translocation occurs as a consequence of ligand-induced 
receptor desensitization. Other receptor-initiated events including induction of IgBct phosphory- 
lation, expression of c-jun and junB mRNA, and costimulatory effects on IL-2 synthesis also 
are altered by IL-1 receptor desensitization.  IL-1 receptor desensitization is not initiated by tumor 
necrosis factor, which also stimulates NF-KB translocation, and is not a consequence of alterations 
in either IL-1  receptor expression or binding at~nity.  In the absence of IL-1,  the effects of 
desensitization are completely reversed within 18 h. Since IL-1 desensitization is initiated under 
conditions of low receptor occupancy, it is likely that receptor desensitization results from alterations 
to a receptor-proximal transducer, rather than from direct modification of the IL-1  receptor. 
These results suggest that the cyclic nature of the events in the T helper lymphocyte activation 
program can be controlled, in part, by the reversible desensitization of cell surface IL-1 receptors. 
I 
L-1 receptor- and TCR-initiated intracellular signals have 
been shown to interact synergistically  to increase the ex- 
pression of multiple lymphokine and lymphokine receptor 
gene products during the competence phase of the T helper 
activation program (1-5). The proliferative component of the 
T  cell activation program is augmented because of the in- 
creased production of lymphokines (IL-2 or -4) binding in 
an autocrine or paracrine manner to high affinity lymphokine 
receptors. Although T lymphocytes express two IL-1 receptor 
isoforms (types I and II), biological responses elicited by IL-1 
are initiated as a consequence of ligation of only type I IL-1 
receptors (6-8). 
In contrast to the large body of information that has accu- 
mulated about TCK-initiated second messenger signaling 
events, the intracellular events initiated by IL-1 receptor liga- 
tion are comparatively ill-defined. The most receptor-proximal 
events resulting from IL-1 receptor ligation in T  lympho- 
cytes are associated with the cytosolic to nuclear transloca- 
tion of the transcription factor,  NF-xB (9).  NF-~cB can be 
detected in the nucleus 5-10 min after stimulation by IL-1 
or other receptor-initiated events or pharmacologic agents. 
NF-KB nuclear translocation occurs as a consequence of the 
NF-~B complex dissociating from its cytosolic inhibitory pro- 
tein, IKB (10-12).  This dissociation is temporally preceded 
by phosphorylation of IKBOt (13-15). However, it is unclear 
whether the inducible phosphorylation of IxB affects IKB- 
NF-gB dissociation or the subsequent degradation of dis- 
sociated  boB. 
The principle transactivating form of NF-~B in T  cells, 
which is comprised of a p50-p65 hetetodimer, binds to specific 
DNA target sequences in the enhancer of a variety of genes 
(16). In T lymphocytes, NF-xB has been shown to be an im- 
portant regulator of genes including lymphokines (1L-2 and 
GM-CSF) (17, 18), the IL-2 receptor tx chain (19, 16), and 
the HIV LTR (20-22).  The lymphokine genes are rapidly 
turned on during the initial phase of the T  cell activation 
program and are subsequently turned offas the cells progress 
through the later stages of the activation program. Thus, 
receptor-initiated events that regulate the T  cell activation 
program must have stir-limiting control mechanisms. In this 
report we characterize the intraceilnlar events associated with 
the transient nuclear translocation of NF-r,B induced by IL-1. 
Results from these analyses demonstrate that in addition to 
rapidly inducing NF-xB nuclear translocation and the expres- 
sion of several immediate early response genes, IL-1 also in- 
itiates desensitization of IL-1 receptor-initiated intracellular 
signaling events. The ligand-induced desensitization of IL-1 
receptor signaling events likdy results from an uncoupling 
of the IL-1 receptor from a receptor-proximal transducer by 
a NF-KB independent mechanism, rather than by alterations 
in receptor expression  or binding aiSnity for IL-1. 
Materials and Methods 
Cells and Cell Cultur~  Jurkat T cells expressing  the routine type 
I IL-1 receptor (Ju.1 cells) were produced by sorting ceUs trans- 
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(Bankers-Fulbright,  J., manuscript in preparation). LBRM 33 cells, 
derived from a murine T cell lymphoma, were obtained from the 
American Type Culture Collection (ATCC; Rockville, MD). Both 
cell fines  were cultured  in spinner  flasks  in medium containing  1LPMI 
1640, 10% calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 
100 #tg/ml streptomycin, 50/~M 2-Me, and 10 mM hepes, pH 7.3. 
Ju.1 cell culture medium also contained 400/~g/ml  hygromycin. 
CD4 § secondary T lyrnphocytes were prepared from RA.LB/c 
lymph node plus spleen cells that had been depleted of CD8 ~ T 
cells using  magnetic  column  separation (biotinylated 53-6.72 
[ATCC, TIB  105] plus strepavidin magnetic beads) (23). Cells 
were stimulated for 10-14 d with anti-CD3 antibody plus lym- 
phokines (supernatant from Con A-treated rat splenocytes), and 
subsequently depleted of anti-CD8 § T  cells, and class II- and 
Ig-positive cells using magnetic column separation. The resulting 
secondary cells, which were >98% CD4 § T lymphocytes  by quan- 
titative immunofluorescence  analysis,  were cultured for 24 h in rIL-2 
(Hoffmann La Roche, Nutley, NJ) before experimental manipu- 
lation. 
Anabodies and Reagents.  Anti-IgBot  (MAD-3) antibody was pre- 
pared by injecting rabbits with an I~BOt (MAD-3) glutathione 
S-transferase (GST-IgS) fusion protein purified  by affanity  chromato- 
graphy (24). Affinity-purified  rabbit antibodies to IgB~ (MAD-3) 
(sc-203), pS0 (sc-114), and 1065 (sc-109) were purchased from Santa 
Cruz Biotechnology, Inc. (Santa Cruz, CA).  Unless otherwise 
noted, other reagents were purchased from Sigma Chemical Co. 
(St.  Louis, MO).  Human recombinant  Iblc~  was  generously 
provided by Dr. John Sims (Immunex Corp., Seattle WA). The 
IL-I~ had asp act of 5.7  x  10  s U//~g protein (U  ffi ECs0 value 
determined in LBRM 33 cell costimulus assay; 25). Unless noted 
otherwise, Ibl was used at a concentration of 200 U/m1. Human 
ffNF-c~ (Genentech, Inc., South San Francisco, CA) was used at 
a concentration of 4 ng/ml. Biotinylated anti-CD3 mAb (ATCC 
CRL 8001; OKT3)  (5-10 /zg/ml) was complexed with avidin 
(10/~g/ml) before being added to call preparations. 
Phosphoprotein Characterization.  3zp-labeled  Ju.1 cells were pre- 
pared by labeling cells with 0.5 mCi/ml 3zPi ([32p]phosphoric add; 
ICN Radiochemicals,  Irvine, CA) for 3 h at 37~  in phosphate- 
free RPMI 1640 medium containing 5%  dialyzed FCS, 2 mM 
L-glutamine, 50/~M 2-ME, and 10 mM Hepes, pH 7.3. Labeled 
cells were divided into aliquots (107Aample) and, after stimulation 
for varying  periods of time, were washed  in ice-cold  PBS wash buffer 
containing 400 ftM Na3VO4, 5 mM EDTA, and 10 mM NaF, pH 
7.4. The ceils were solubilized for 30 min at 40C in lysis buffer 
containing 0.5% Triton X-100, 50 mM Tris hydrochloride, 300 
mM NaC1, 5 mM EDTA, 10 mM iodoacetamide, 1 mM sodium 
orthovanadate, 40 mM/~-glycerol phosphate, 10/~g/ml leupeptin, 
and 10 #g/ml aprotinin, pH 7.6. After centrifugation, lysates  were 
predeared with protein A-Sepharose, and then sequentially  immuno- 
precipitated with normal rabbit IgG and with specific antibodies 
bound to protein A-Sepharose. Immune complex  protein A-Sepha- 
rose beads were washed and subsequently eluted with SDS sample 
buffer. Immunoprecipitates were analyzed on 10% SDS PAGE as 
previously  described (26). Immunoprecipitation experiments were 
performed a minimum of three times. ~rP-labeled proteins were de- 
tected by autoradiography at  -700C for 2-5 d. 
Mobility Shift Assays.  Nuclear  extracts were prepared by the 
method of Dignam et al. (27), with the following exception: cells 
were disrupted by incubating in buffer A containing 0.02 or 0.1% 
NP-40 for 5 min at 4~  Mobility shift reactions  contained 6-15 ftg 
nuclear extract, 0.5-3/~g (poly[dI-dC])  (Sigma  Chemical Co.), and 
15,000 cpm (0.02-0.5 ng) "y-[sZP]ATP  (sp act 3,000 Ci/mmol) end 
labeled, double stranded olignnucleotide in a final volume of 15 
/~1. Protein-DNA complexes  were separated  by PAGE  using a 4.5% 
nondenaturing gel in a high-ionic strength buffer (40 mM Tris, 
384 mM glycine, and 2 mM EDTA, pH 8.3). Specific  binding of 
nuclear proteins to labeled DNA oligonucleotide probes was de- 
termined by competition with unlabeled DNA probes that were 
identical to the labeled  probes, and by competition with unlabeled 
DNA probes that were unrelated to the labeled DNA probes (data 
not shown for the unrelated DNA probes). Each gel shift assay 
was done a minimum of three times. The DNA sequence of the 
IL-2 NF-~B olignnucleotide probe used in this study is as follows 
(5' to 3" coding strand only): CCCGACCAAGAGGGATTTCAC- 
CTAAATC  CATT. 
1I_,2 Bioassay.  IL-2  biologic activity was measured in culture 
supernatants isolated from Ju.1 cells (10  s cells/200/~l/microtiter 
well) that had been stimulated with various reagents for 24 h. The 
II.,2 bioassay  using HT-2 cells has been described previously (28). 
RNAIsolationandAnal?~is.  Expression  of  immediate  early gene 
c~un  and junB mRNA was measured by Northern  blot analysis. 
Ju.1 cells were stimulated for 30 min and total celluhr RNA was 
isolated by lysis of the cells in guanidium isothiocyanate solution 
(29), followed  by cesium chloride centrifugation (30). The isolated 
RNA (30 ~g/lane) was size fractionated  by electrophoresis through 
a 1% agarose gel containing 2.2 M formaldehyde and was trans- 
ferral to Hybond M membrane  filters (Amersham  Corp., Arlington 
Heights, IL). eDNA probes were radiolabded with c~[3Zp]dCTP 
by random primer extension to asp act of '~109 cpm//~g DNA. 
Hybridization was carried out at 42~  for 18 h in 50% forma- 
mide, 5x SSC (lx SSC: 0.15 M NaC1, 0.015 M trisodium citrate), 
5x  Denhardt's  solution, 0.1% SDS, 100/~g/ml  salmon sperm 
DNA, and 50 ttg/ml polyadenylic  add. High stringency  posthybfidi- 
zation washes were performed at 230C in 2x  SSC, 0.1% SDS, 
and at 650C in 0.1x SSC, 0.1% SDS. The amounts of RNA loaded 
on different lanes of each Northern blot were shown to be com- 
parable by probing the blots with glyceraldehyde-3-phosphate  de- 
hydrogenase eDNA  (1.85-kb  Pstl  fragment  from  pIBI  30- 
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH) from Dr. S. 
Kang (Mount Sinai  Medical  Center, New York). The eDNA probes 
used include c-jun (1.8-kb EcoRI fragment) (31) and junB (1.8-kb 
EcoRI fragment) (32), both provided by Dr. D. Nathans (Johns 
Hopkins University, Baltimore, MD). 
12sI-labeled 11.,1 Binding Assays.  Radioreceptor assays were per- 
formed as previously described (6) with mI-Ibl that was gener- 
ously provided by Drs. S. K. Dower andJ. Sims (Immunex Corp.) 
or purchased from New England Nuclear Corp. (Boston, MA). 
Results 
Previous  studies have demonstrated that IL-1 receptor li- 
gation initiates NF-gB nudear translocation (9).  Gel shift 
analyses performed with type  1 IL-1 receptor  transfected 
human Jurkat T cells (Ju.1 cells) (Fig. 1) and murine LBRM 
33 cells (data not shown) have demonstrated that IL-l-initi- 
ated NF-KB nuclear translocation is detectable within 5-10 
min and is maximal at 30-60 rain (Fig. 1). Although cyto- 
solic NF-rB is restored 1 h  after IL-1 stimulation because 
of de novo NF-rB synthesis, preliminary experiments demon- 
strated that the continued presence of IL-1 does not stimu- 
late nuclear translocation of this newly synthesized NF-rB 
(data not shown). Consequently, NF-KB DNA binding ac- 
tivity is minimal in nuclear extracts isolated from T cells that 
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NF-KB  nuclear translocation. Nuclear 
extracts were prepared from Ju.1 cells 
stimulated with 11,1 for the indicated 
times (minutes). A 32P-labeled  DNA 
probe  encompassing  the  NF-KB 
binding  motif  from the mouse I1-2  en- 
hancer was incubated with the nuclear 
extracts and the protein-DNA com- 
plexes analyzed using  electrophoretic 
mobility shift assay (EMSA)I. Pre- 
liminary experiments  demonstrated 
that the upper  band  consists  primarily 
of p65 and p50 polypeptides  whereas 
the minor  lower  band  consists  of pS0 
polypeptides. 
have been stimulated by IL-1 for 2-4 h  (Hg.  1). These ki- 
netic analyses of IL-l-initiated NF-xB DNA binding activity 
suggest that IL-1 receptor ligation initiates a rapid, but tran- 
sient NF-~B nuclear translocation stimulus in T lymphocytes. 
To characterize  the mechanism responsible for the transient 
IL-l-initiated  NF-~B  nuclear  localization,  we  evaluated 
whether IL-l-pretreated cells could respond to homologous 
(IL-1) or heterologous (TNF-ol) receptor-initiated signals with 
NF-~B nuclear translocation. Ju.1 cells were cultured with 
IL-1 for  16 h, washed, and then restimulated for 30 min 
with either I1-1 or TNF-ol. Gel shift analysis (Fig. 2) demon- 
st=ted that TNF stimulates comparable levels of NF-xB trans- 
location in either untreated or IL-l-pretreated  Ju.1 cells. These 
results demonstrate that heterologous cell surface receptor-ini- 
tiated signals can stimulate normal levels of NF-~B nuclear 
translocation in IL-1-pretreated cells. However, IL-l-induced 
NF-~B translocation is largely absent in cells pretreated with 
IL-1 for either 4 h (data not shown) or 16 h (Fig. 2) as com- 
pared with the IL-l-initiated response in cells that were not 
pretreated.  Comparable results also have been obtained in gel 
shift analyses of extracts prepared from LBRM 33 cells (data 
not shown). 
In this Ju.1 model system, signals initiated through the 
IL-t receptor interact synergistically with antigen receptor-ini- 
tiated signals to upregulate the production of IL-2. NF-KB 
is the predominant IL-l-responsive transcription factor in the 
IL-2 enhancer (KaUi, K., manuscript in preparation). If un- 
1 Abbr~tion used in this  palm: EMSA, eleetrophoretic mobility shift assay. 
Figure 2.  I1,1  pretreatment of 
Ju.1 cells initiates desensitization 
by homologous  but not heterol- 
ogous  stimuli. Ju.1  cells were 
stimulated for 30 min with IL-1 
or TNF after being cultured for 
16  b  in  either  medium  or  in 
medium containing  I1,1. Nuclear 
extracts were prepared from the 
cells, incubated with a 32P-labeled 
NF-xB  probe,  and  the  pro- 
tein-DNA complexes were ana- 
lyzed by EMSA. Samples in lanes 
2 and 7 are duplicate samples  using 
the same  cell  extract. ILl plus cold 
probe (I1,1 +  CP) is the nuclear 
extract  isolated  from Ju.1  cells 
stimulated for 30 min (lanes  2 and 
7 sample) incubated with the 32p. 
labeled probe in the presence of 
e~cess unlabeled  NF-s~B probe. 
(PROBE)  32P-labeled NF-KB 
probe only, 
coupling of the IL-1 receptor-induced NF-gB response occurs 
in vivo, we would expect II,-1 pretreatment to affect the IL-2 
response elicited by the combination of anti-CD3 plus IL-1. 
Ju.1 cells were stimulated with varying concentrations of anti- 
CD3 antibody in the presence or absence of exogenous IL-1 
(Fig. 3). In theJurkat model system, anti-CD3 antibody treat- 
ment alone is insutficient to stimulate detectable IL-2 release. 
However,  IL-2 production is increased in a concentration- 
dependent manner in response to stimulation by anti-CD3 
and IL-1. In contrast, Ju.1 cells that have been pretreated with 
IL-1 do not produce a detectable IL-2 response when stimu- 
lated with anti-CD3  and IL-1. 
One of the most receptor-proximal events detectable after 
stimulating Ju.1 cells with IL-1  is the phosphorylation of 
the cytosolic NF-s~B inhibitor, Ir,  Ba (13). This ligand-induced 
phosphorylation  has been temporally associated with NF-KB 
nuclear translocation (13, 14). IKB~x  is inducibly phosphory- 
lated within 2 rain after I1-1 or TNF addition (Fig. 4). SDS- 
PAGE analysis of anti-I~B immunoprecipitates  isolated from 
32p-labeled, untreated Ju.1 cells shows a constitutively phos- 
phorylated IKBol band (oo37 kD; bottom arrow in Fig. 4). 
In IL-1- or TNF-treated cells, the 37-kD IxBc~  band decreases 
in intensity, whereas a concomitant increase is observed in 
a slightly higher molecular weight band (•40  kD) resulting 
from the inducible phosphorylation of the IKBcz  polypeptide 
(top arrow in Fig.  4).  IL-1 pretreated Ju.1 cells have com- 
parable levels of constitutively phosphorylated IKBo~ as un- 
treated cells, and the addition of TNF to IL-1 pretreated cells 
results in an upshift of the phosphorylated IgBol band that 
is comparable to the TNF-induced phosphorylation observed 
in  untreated Ju.1  cells. In contrast,  stimulation of IL-1- 
pretreated cells with IL-1 fails to initiate detectable changes 
in either the constitutively pbosphorylated or the inducibly 
phosphorylated IgBo~ band. 
To determine if the inhibition of the IL-1 receptor desen- 
sitization is mediated by NF-gB, Ju.1 cells were pretreated 
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Figure  3.  II-2 responses elicited  by anti-CD3 and I1.1 are 
inhibited  by II~1 pretreatment of  Ju.1 cells.  Ju.1 cells (untreated 
or pretrcated with ILl overnight) were washed and then stimu- 
lated with varying concentrations of anti-CD3 in the pres- 
ence or absence of I1.1 (10 U/nil). Supernatants were har- 
vested after 24  h  and II.,2 in the culture supernatants was 
quantitated using the [~2-dependent cell line, HT-2 (40). Data 
points represent mean values from quadruplicate measurements 
of [3H]thymidine incorporation in the HT-2 bioassay. 
Figure  4.  Homologous desensitization of receptor-initiated  Ir,  B phos- 
phorylation. Untreated, I1.1 pretreated (18 h), or TNF pretreated (18 h) 
Ju.1 cells were loaded with [~2P]phosphoric acid, washed,  and stimulated 
for 10 rain with I1.1 or TNF. Detergent lysates of the cells were immuno- 
precipitated with anti-IxB,  and the immunoprecipitates analyzed by SDS 
PAGE. 
with TNF for 16 h and then restimulated with IL-1 or TNF 
(Fig. 4). Analysis  of anti-I~B immunopredpitates demonstrates 
that TNF-pretreated Ju.1 cells exhibit an Ir~B phosphoryla- 
tion pattern similar to that observed in untreated cells. IL-1 
inducibly phosphorylates  boB in the TNF-treated cells, but 
TNF does not. We have not pursued experiments to identify 
potential mechanisms  responsible  for  the  observed  TNF- 
mediated  effects. The experiments  demonstrate that  TNF 
receptor-initiated signals, which are capable of translocating 
NF-KB, do not induce IL-1 receptor desensitization.  Collec- 
tively, the results demonstrate that Ju.1 cells that have been 
pretreated  with IL-1 do not respond with inducible phos- 
phorylation of IKB by homologous receptor-initiated signals 
but can be stimulated by heterologous receptor-initiated signals 
that are capable of inducing NF-~B nuclear  translocation. 
Northern blot analyses  ofc-Jun andjunB  mRNA were used 
to evaluate IL-1 receptor desensitization effects on activation 
responses that are not directly associated with NF-KB. The 
inducible expression of c-Jun andjunB mRNA by IL-1 or 
tetradecanoylphorbol  acetate (TPA) is readily detectable in 
Ju.1  cells 30 min after stimulation (Fig. 5). Although the 
regulatory mechanisms  mediating IL-1 induction of these 
genes are incompletely understood, their transcriptional regu- 
lation appear to be independent of NF-KB (32, 33). Northern 
blot analysis  demonstrated that TPA induces comparable levels 
of both c-Jun mRNA andjunB  mRNA in untreated and IL- 
1-pretreated  Ju.1 cells. In contrast,  although IL-1 induces 
the production of c-Jun andjunB mRNA in untreated Ju.1 
cells, it does not induce the production of c-jun and junB 
mRNA in IL-l-pretreated cells (Fig. 5). These results sug- 
gest that IL-1 receptor-distal,  NF-KB-independent responses 
are also refractory to homologous receptor-initiated signals 
but not to pharmacologic stimuli in cells pretreated with IL-1. 
The selective loss of IL-1 responses in IL-l-pretreated Ju.1 
cells could result from the absence of unoccupied cell surface 
IL-1 receptors  at the end of the IL-1 pretreatment period. 
To comparatively  evaluate the number of unoccupied IL-1 
receptors on untreated and IL-l-pretreated  Ju.1 cells, binding 
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production of c-jun andjunB mRNA. Two Northern blots were used to 
characterize the inducible expression of c-jun andjunB mRNA in untreated 
or I1-1-pretreated Ju.1 ceils that had been stimulated with I1-1 or TPA 
(20 ng/ml) for 30 rain. Northern blots were probed sequentially with 
c-jun orjunB and GAPDH cDNAs. Autoradiographs of  the two Northern 
blots were exposed for comparable periods of time. 
analyses were performed with 12SI-labded IL-1.  Results in 
Table I demonstrate that untreated Ju.1 cells express ,'~4,900 
unoccupied receptors per cell whereas IL-l-pretreated cells 
express "~3,900 unoccupied receptors per cell.  The Kd cal- 
culated from the IL-1 binding analyses on untreated and IL- 
1-pretreated cells were comparable to each other and to pre- 
viously published values for type I IL-1 receptors (34). We 
and others (6, 35) have demonstrated previously that as few 
as 10 ligated IL-1 receptors per cell are needed to elicit a bio- 
logic response from T  lymphocytes (6, 35).  Thus, it is un- 
likely that the homologous desensitization initiated by IL-1 
pretreatment of the Ju.1 cells results from the absence of un- 
ligated IL-1  receptors on the surface of these cells. 
Receptor desensitization should be followed by a time- 
dependent recovery of IL-l-mediated function once excess 
IL-1 is removed from the T cell culture. To evaluate the ki- 
netics of receptor recovery,  IL-l-pretreated Ju.1 cells were 
washed free of IL-1, and cultured for varying periods of time 
in medium before being restimulated for 30 min with IL-1. 
As shown in Fig.  6, a detectable increase in IL-l-initiated 
NF-gB translocation can be observed after 2 h  of culture, 
with full functional recovery by 18 h. These results demon- 
strate that in IL-l-pretreated cells, IL-1 receptors recover their 
functional activity in a time-dependent manner. 
We previously demonstrated that primary murine CD4 + 
T lymphocytes express no detectable IL-1 receptors and un- 
dergo no detectable IL-l-mediated biological responses (Pod- 
zorski, R., manuscript submitted for publication). However, 
secondary CD4 + T  call  populations derived from stimu- 
lating lymph node/spleen-derived  T cells with anti-CD3 an- 
tibody and lymphokines for 10-14 d express detectable levels 
of functional type I IL-1 receptors.  Preliminary experiments 
demonstrate that IL-l-stimulated NF-KB nuclear transloca- 
tion is maximal in nuclear extracts from cells stimulated with 
IL-1 for 15 rain, and is reduced to near background in cells 
stimulated for 30 min (data not shown). To determine ffIL-1- 
pretreated CD4 + secondary T lymphocytes are refractory to 
homologous  receptor-initiated NF-gB trandocafion, secondary 
lymphocytes were cultured overnight in either the presence 
or absence of IL-1, washed, and then restimulated with IL-1 
or TNE  The gd shift analysis in Fig. 7 shows that TNF 
stimulates NF-KB translocation in untreated and in IL-l-pre- 
treated secondary CD4 + T  lymphocytes. In contrast, IL-1 
stimulates NF-JcB nuclear translocation from untreated but 
not from IL-l-pretreated CD4 + T  lymphocytes. The rela- 
tively small amount of NF-KB nuclear translocation observed 
in extracts  from the IL-l-treated CD4 + T  lymphocytes (as 
compared to the Ju.1 cells) probably results from the pres- 
ence of IL-1 receptors on only a subset of the secondary T 
lymphocytes. Collectively,  the results presented are consis- 
tent with the hypothesis that IL-1 receptor ligation dicits 
intracdlular signals that stimulate the T cell activation pro- 
Table  1.  Unligated IL-I  Receptors on Ju.l  Cells  Treated 18 h 
with rlL-Ic~ 
Pretreatment  Ka(x  10 -1~  Sites/cell 
Medium  8.65  4,866  •  341 
IL-1  8.40  3,898  •  273 
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Figure  6.  Kinetics  of  the 
recovery of  lbl-inducible  NF-KB 
from I1,1-desensitized Ju.1 cells. 
Ju.1 cells were pretreated for 18 h 
with II-1, washed,  and cultured 
for 1, 2, 4, 6, or 18 h. Cells were 
subsequently  restimulated  with 
I1-1 for 30 rain and nuclear e~- 
tracts from the cells  were analyzed 
for NF-gB DNA binding  activity 
by ~.MSA. Figure 7.  IL,1  pretreatment of 
CD4 +  T  lymphocytes inhibits 
homologous but not heterologous 
ligand-induced  NF-rB  nuclear 
localization. CD4 +  T  lympho- 
cytes (cultured 18 h in the pres- 
ence  or  absence  of  Ibl)  were 
stimulated for the times indicated 
(minutes) with IL-1 or TNF, and 
nuclear  extracts  from  the  cells 
were analyzed for NF-rB DNA 
binding activity by EMSA. (CP) 
The  15-min  IL-1 treated extract 
(lane  2)  incubated with  32p-la- 
beled NF-gB probe plus unhbded 
NF-rB  probe.  (P)  32p-labeled 
NF-rB probe only. 
gram as well as signals that uncouple the receptor from down- 
stream signaling pathways. 
Discussion 
The T  helper lymphocyte activation program consists of 
a coordinated series of gene activation and inactivation events 
that result in antigen receptor-stimulated T cells transiting 
through the competence (lymphokine  and lymphokine  recep- 
tor expression) and progression (lymphokine receptor medi- 
ated) phases of the cell cycle. Antigen receptor-initiated signals, 
which alone elicit  suboptimal activation responses,  usually 
require additional signals generated by IL-1 or other costimula- 
tory receptors (CD28) to maximally initiate the T ceU acti- 
vation program. IL-1 receptor ligation rapidly induces the 
production of transcription factors that interact cooperatively 
with antigen receptor-activated transcription factors to stimu- 
late gene expression  events in the competence phase of the 
activation program. 
Studies characterizing the IL-1 receptor-proximal events 
in human and routine T cell model systems have demonstrated 
that IL-1 initiates phosphorylation of IrBo~ (13) and dissoci- 
ation of IrBcx from NF-rB. The dissociated IrBol is rapidly 
degraded in the cytosol (13-15). The NF-rB complex trans- 
locates to the nudens where it binds to target sequences and 
positively regulates a variety of gene enhancers, including IgBo~ 
(36) and the p105 precursor of the NF-gB p50 polypeptide 
(37). As a consequence of the IL-l-induced NF-rB nuclear 
translocation,  IrBol and p105 polypeptide synthesis is induced 
and these proteins reappear in the cytoso160 min before stim- 
ulation. Although IL-1 is a potent stimulus to initiate NF-rB 
nuclear translocation,  gd shift (Fig. 1) and Western blot (data 
not shown) analyses demonstrate that NF-rB is largdy gone 
from the nucleus 4 h after IL-1 has been added to the cells. 
Thus, the transient localization of IL-l-induced NF-rB DNA 
binding activity in the nucleus of human  Ju.1 and in murine 
LBRM 33 cells occurs at the same time that abundant levels 
of IrB-NF-rB complexes exist in the cytosol of IL-l-treated 
cells. The cytosolic NF-~B complexes in IL-l-pretreated calls 
were shown to be translocation competent by demonstrating 
that TNF induced NF-rB nuclear translocation (Fig. 2). These 
observations suggested that either cell surface IL-1 receptors 
on the IL-l-pretreated cells were not available for ligation, 
or that the IL-1 receptors were uncoupled from downstream 
signaling pathways. 
The amount of IL-lcx added to the Ju.1 cell cultures to 
elicit the desensitization response was calculated to ligate only 
a fraction of the cell surface receptors.  Binding assays with 
nSI-labeled IL-1 on untreated and IL-l-pretreated Ju.1 cells 
demonstrated that the IL-l-pretreated cells have, on average, 
more than 3,900 unligated receptors per cell (Table 1). In ad- 
dition, the af~nity of the available receptors was unaffected 
by the IL-1 pretreatment. Concentration-response analyses 
of murine CD4 +dones T.2 (6) have confirmed a previous 
report (35) that as few as 10 type I IL-1 receptors need to 
be ligated to initiate 50% of the maximal biological responses 
from cells, Thus, it is clear that the availability of cell surface 
IL-1 receptors is not responsible for the desensitization phe- 
nomenon. Given the low level of receptor occupancy needed 
to elicit an IL-1 response in T cells, it is not surprising that 
a mechanism exists to desensitize IL-1 receptor responses after 
receptor ligation. 
Uncoupling the IL-1 receptor from intraceUular signaling 
pathways could occur by modification of one or more com- 
ponents of the signaling pathway or by a direct modification 
of the IL-1 receptor. The most IL-1 receptor-proximal events 
we have measured in T cells have been associated with NF-rB 
nuclear translocation. In addition to inhibiting homologous 
ligand-induced nuclear translocation of the NF-rB complex, 
phosphorylation of IrBc~, which is detectable within 2 min 
after ligation of the receptor, also is blocked by IL-1 pretreat- 
merit (Fig.  4).  Although multiple intracellular events have 
been associated with IL-1  receptor ligation in a variety of 
cell  types,  the  signal  transduction pathway linking IL-1 
receptors to posttranslational modifications of IrB remains 
unidentified. TNF receptor ligation, which also stimulates 
IrB phosphorylation and NF-rB nuclear translocation, does 
not  initiate  IL-1  receptor desensitization.  Thus,  the IL-1 
receptor-initiated signal responsible  for the receptor desen- 
sitization is not NF-rB  dependent. The synthesis of c-jun 
andjunBmRNA,  which are IL-1 receptor-distal, NF-rB- 
independent events,  also is inhibited by IL-1  pretreatment 
(Fig. 5). Together these results demonstrate that IL-1 pretreat- 
ment of Ju.1 cells may inhibit multiple IL-1 receptor-initi- 
ated signaling events and, consequently, suggest that the un- 
coupling event is very proximal to the IL-1 receptor.  The 
observation that IL-1 pretreatment of Ju.1 cells inhibits the 
production of IL-2 elicited by the synergistic stimuli of anti- 
CD3 plus IL-1 clearly demonstrates the biological relevance 
of IL-1 receptor desensitization. 
The uncoupling of IL-l-initiated signals from downstream 
responses could result from a direct modification of the IL-1 
1326  Homologous Desensitization of Ibl Receptors receptor. One report indicated that IL-1 initiates phosphory- 
lation of the type I IL-1 receptor in COS cells (38).  How- 
ever,  we have been unable to reproduce these experiments 
in LBRM 33 cells (Abraham,  R.T., and D.J. McKean, un- 
published results). Ju.1 cells and LBRM 33 cells each express 
approximately 5,000 IL-1 receptors per cell. Concentrations 
of IL-1 that result in maximal IL-1 receptor desensitization 
occupy only ~20%  of the cell surface receptors.  Since,  as 
discussed above, there are a large number of spare IL- 1 receptors 
in these T cell model systems, IL-1 pretreatment would have 
to affect essentially all of the Ju.1 IL-1 receptors to abrogate 
the IL-l-induced response. Thus, it is likely that the desen- 
sitization event occurs at the level of a receptor-proximal trans- 
ducer rather than by a direct posttranslational  modification 
of the IL-1 receptor. This postreceptor desensitization event 
is an obvious potential target for therapeutically antagonizing 
IL-1 effects in vivo. 
In IL-1 receptor-positive normal secondary CD4 + T lym- 
phocytes and in TH2 clones, IL-1  alone does not elicit the 
expression of lymphokines  or lymphokine receptor genes. 
However, IL-1 does provide a potent  costimulatory signal 
to augment  antigen  receptor-initiated  activation responses 
in T lymphocytes. The IL-1 costimulatory activity is medi- 
ated,  in part, by the enhanced production/activity of tran- 
scription factors, NF-~B (33) and AP-1 (39). These proteins 
can potentially affect the rate of transcription of many genes 
involved in the T lymphocyte activation program.  Previous 
studies (1, 2, 4, 5) have indicated that  the primary role for 
IL-1 in the T cell activation program is to upregulate genes 
in the competence phase. IL-1 receptor desensitization may 
effectively contribute to focusing the effects of IL-1 in the 
competence phase of the activation program where upregu- 
lation of lymphokine and lymphokine receptor genes is im- 
portant.  It also is possible that transcription  factors, which 
have positive effects on gene expression in the competence 
phase of the activation program,  have negative effects when 
combined  with  transactivating  proteins  produced  in  later 
phases of the activation program. 
The transient  nature of the receptor desensitization  also 
may enable cells to regain IL-1 responsiveness as the activated 
T  cell returns  to the G1 phase of the cell cycle.  Regaining 
IL-1 responsiveness after the antigen receptor has been func- 
tionally downregulated or physically cleared from the cell sur- 
face would be expected to preclude additional IL-1 augmen- 
tation of lymphokine gene expression.  Although lymphokine 
gene expression in activated T  cells is transient,  additional 
rounds of cell division can occur if the cells are stimulated 
through lyrnphokine receptors in a paracrine manner. Thus, 
the subsequent acquisition of IL-1 responsiveness  could reflect 
a potential uncharacterized role for IL-1 in the progression 
phase of the T  cell activation  program. 
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